Global Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), By Application (Oncology, Neurology, Cardiology, and other Applications), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2032

Published date: Nov 2023
Report ID: 21356
Number of Pages: 232
Format:

- - 1. Executive Summary
    1.1. Definition
    1.2. Taxonomy
    1.3. Research Scope
    1.4. Key Analysis
    1.5. Key Findings by Major Segments
    1.6. Top strategies by Major Players
  - 2. Global Radiopharmaceutical Market Overview
    2.1. Radiopharmaceutical Market Dynamics
    2.1.1. Drivers
    2.1.2. Opportunities
    2.1.3. Restraints
    2.1.4. Challenges
    2.2. Macro-economic Factors
    2.3. Regulatory Framework
    2.4. Market Investment Feasibility Index
    2.5. PEST Analysis
    2.6. PORTER’S Five Force Analysis
    2.7. Drivers & Restraints Impact Analysis
    2.8. Industry Chain Analysis
    2.9. Cost Structure Analysis
    2.10. Marketing Strategy
    2.11. Russia-Ukraine War Impact Analysis
    2.12. Opportunity Map Analysis
    2.13. Market Competition Scenario Analysis
    2.14. Product Life Cycle Analysis
    2.15. Opportunity Orbits
    2.16. Manufacturer Intensity Map
    2.17. Major Companies sales by Value & Volume
  - 3. Global Radiopharmaceutical Market Analysis, Opportunity and Forecast, 2016-2032
    3.1. Global Radiopharmaceutical Market Analysis, 2016-2021
    3.2. Global Radiopharmaceutical Market Opportunity and Forecast, 2023-2032
    3.3. Global Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Type, 2016-2032
    3.3.1. Global Radiopharmaceutical Market Analysis by Type: Introduction
    3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
    3.3.3. Diagnostic Nuclear Medicine
    3.3.4. Therapeutic Nuclear Medicine
    3.4. Global Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Application, 2016-2032
    3.4.1. Global Radiopharmaceutical Market Analysis by Application: Introduction
    3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
    3.4.3. Neurology
    3.4.4. Cardiology
    3.4.5. Oncology
    3.4.6. Other Applications
    3.6. Global Radiopharmaceutical Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    3.6.1. Global Radiopharmaceutical Market Analysis by End-User: Introduction
    3.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    3.6.3. Hospitals
    3.6.4. Ambulatory Surgical Centers
    3.6.5. Diagnostic Centers
    3.6.6. Cancer Research Institutes
    3.6.7. Other end-users
  - 4. North America Radiopharmaceutical Market Analysis, Opportunity and Forecast, 2016-2032
    4.1. North America Radiopharmaceutical Market Analysis, 2016-2021
    4.2. North America Radiopharmaceutical Market Opportunity and Forecast, 2023-2032
    4.3. North America Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Type, 2016-2032
    4.3.1. North America Radiopharmaceutical Market Analysis by Type: Introduction
    4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
    4.3.3. Diagnostic Nuclear Medicine
    4.3.4. Therapeutic Nuclear Medicine
    4.4. North America Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Application, 2016-2032
    4.4.1. North America Radiopharmaceutical Market Analysis by Application: Introduction
    4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
    4.4.3. Neurology
    4.4.4. Cardiology
    4.4.5. Oncology
    4.4.6. Other Applications
    4.6. North America Radiopharmaceutical Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    4.6.1. North America Radiopharmaceutical Market Analysis by End-User: Introduction
    4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    4.6.3. Hospitals
    4.6.4. Ambulatory Surgical Centers
    4.6.5. Diagnostic Centers
    4.6.6. Cancer Research Institutes
    4.6.7. Other end-users
    4.CN. North America Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    4.CN.1. North America Radiopharmaceutical Market Analysis by Country : Introduction
    4.CN.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    4.CN.2.1. The US
    4.CN.2.2. Canada
    4.CN.2.3. Mexico
  - 5. Western Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, 2016-2032
    5.1. Western Europe Radiopharmaceutical Market Analysis, 2016-2021
    5.2. Western Europe Radiopharmaceutical Market Opportunity and Forecast, 2023-2032
    5.3. Western Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Type, 2016-2032
    5.3.1. Western Europe Radiopharmaceutical Market Analysis by Type: Introduction
    5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
    5.3.3. Diagnostic Nuclear Medicine
    5.3.4. Therapeutic Nuclear Medicine
    5.4. Western Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Application, 2016-2032
    5.4.1. Western Europe Radiopharmaceutical Market Analysis by Application: Introduction
    5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
    5.4.3. Neurology
    5.4.4. Cardiology
    5.4.5. Oncology
    5.4.6. Other Applications
    5.6. Western Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    5.6.1. Western Europe Radiopharmaceutical Market Analysis by End-User: Introduction
    5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    5.6.3. Hospitals
    5.6.4. Ambulatory Surgical Centers
    5.6.5. Diagnostic Centers
    5.6.6. Cancer Research Institutes
    5.6.7. Other end-users
    5.CN. Western Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    5.CN.1. Western Europe Radiopharmaceutical Market Analysis by Country : Introduction
    5.CN.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    5.CN.2.1. Germany
    5.CN.2.2. France
    5.CN.2.3. The UK
    5.CN.2.4. Spain
    5.CN.2.5. Italy
    5.CN.2.6. Portugal
    5.CN.2.7. Ireland
    5.CN.2.8. Austria
    5.CN.2.9. Switzerland
    5.CN.2.10. Benelux
    5.CN.2.11. Nordic
    5.CN.2.12. Rest of Western Europe
  - 6. Eastern Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, 2016-2032
    6.1. Eastern Europe Radiopharmaceutical Market Analysis, 2016-2021
    6.2. Eastern Europe Radiopharmaceutical Market Opportunity and Forecast, 2023-2032
    6.3. Eastern Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Type, 2016-2032
    6.3.1. Eastern Europe Radiopharmaceutical Market Analysis by Type: Introduction
    6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
    6.3.3. Diagnostic Nuclear Medicine
    6.3.4. Therapeutic Nuclear Medicine
    6.4. Eastern Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Application, 2016-2032
    6.4.1. Eastern Europe Radiopharmaceutical Market Analysis by Application: Introduction
    6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
    6.4.3. Neurology
    6.4.4. Cardiology
    6.4.5. Oncology
    6.4.6. Other Applications
    6.6. Eastern Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    6.6.1. Eastern Europe Radiopharmaceutical Market Analysis by End-User: Introduction
    6.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    6.6.3. Hospitals
    6.6.4. Ambulatory Surgical Centers
    6.6.5. Diagnostic Centers
    6.6.6. Cancer Research Institutes
    6.6.7. Other end-users
    6.CN. Eastern Europe Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    6.CN.1. Eastern Europe Radiopharmaceutical Market Analysis by Country : Introduction
    6.CN.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    6.CN.2.1. Russia
    6.CN.2.2. Poland
    6.CN.2.3. The Czech Republic
    6.CN.2.4. Greece
    6.CN.2.5. Rest of Eastern Europe
  - 7. APAC Radiopharmaceutical Market Analysis, Opportunity and Forecast, 2016-2032
    7.1. APAC Radiopharmaceutical Market Analysis, 2016-2021
    7.2. APAC Radiopharmaceutical Market Opportunity and Forecast, 2023-2032
    7.3. APAC Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Type, 2016-2032
    7.3.1. APAC Radiopharmaceutical Market Analysis by Type: Introduction
    7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
    7.3.3. Diagnostic Nuclear Medicine
    7.3.4. Therapeutic Nuclear Medicine
    7.4. APAC Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Application, 2016-2032
    7.4.1. APAC Radiopharmaceutical Market Analysis by Application: Introduction
    7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
    7.4.3. Neurology
    7.4.4. Cardiology
    7.4.5. Oncology
    7.4.6. Other Applications
    7.6. APAC Radiopharmaceutical Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    7.6.1. APAC Radiopharmaceutical Market Analysis by End-User: Introduction
    7.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    7.6.3. Hospitals
    7.6.4. Ambulatory Surgical Centers
    7.6.5. Diagnostic Centers
    7.6.6. Cancer Research Institutes
    7.6.7. Other end-users
    7.CN. APAC Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    7.CN.1. APAC Radiopharmaceutical Market Analysis by Country : Introduction
    7.CN.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    7.CN.2.1. China
    7.CN.2.2. Japan
    7.CN.2.3. South Korea
    7.CN.2.4. India
    7.CN.2.5. Australia & New Zeland
    7.CN.2.6. Indonesia
    7.CN.2.7. Malaysia
    7.CN.2.8. Philippines
    7.CN.2.9. Singapore
    7.CN.2.10. Thailand
    7.CN.2.11. Vietnam
    7.CN.2.12. Rest of APAC
  - 8. Latin America Radiopharmaceutical Market Analysis, Opportunity and Forecast, 2016-2032
    8.1. Latin America Radiopharmaceutical Market Analysis, 2016-2021
    8.2. Latin America Radiopharmaceutical Market Opportunity and Forecast, 2023-2032
    8.3. Latin America Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Type, 2016-2032
    8.3.1. Latin America Radiopharmaceutical Market Analysis by Type: Introduction
    8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
    8.3.3. Diagnostic Nuclear Medicine
    8.3.4. Therapeutic Nuclear Medicine
    8.4. Latin America Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Application, 2016-2032
    8.4.1. Latin America Radiopharmaceutical Market Analysis by Application: Introduction
    8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
    8.4.3. Neurology
    8.4.4. Cardiology
    8.4.5. Oncology
    8.4.6. Other Applications
    8.6. Latin America Radiopharmaceutical Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    8.6.1. Latin America Radiopharmaceutical Market Analysis by End-User: Introduction
    8.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    8.6.3. Hospitals
    8.6.4. Ambulatory Surgical Centers
    8.6.5. Diagnostic Centers
    8.6.6. Cancer Research Institutes
    8.6.7. Other end-users
    8.CN. Latin America Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    8.CN.1. Latin America Radiopharmaceutical Market Analysis by Country : Introduction
    8.CN.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    8.CN.2.1. Brazil
    8.CN.2.2. Colombia
    8.CN.2.3. Chile
    8.CN.2.4. Argentina
    8.CN.2.5. Costa Rica
    8.CN.2.6. Rest of Latin America
  - 9. Middle East & Africa Radiopharmaceutical Market Analysis, Opportunity and Forecast, 2016-2032
    9.1. Middle East & Africa Radiopharmaceutical Market Analysis, 2016-2021
    9.2. Middle East & Africa Radiopharmaceutical Market Opportunity and Forecast, 2023-2032
    9.3. Middle East & Africa Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Type, 2016-2032
    9.3.1. Middle East & Africa Radiopharmaceutical Market Analysis by Type: Introduction
    9.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
    9.3.3. Diagnostic Nuclear Medicine
    9.3.4. Therapeutic Nuclear Medicine
    9.4. Middle East & Africa Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Application, 2016-2032
    9.4.1. Middle East & Africa Radiopharmaceutical Market Analysis by Application: Introduction
    9.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
    9.4.3. Neurology
    9.4.4. Cardiology
    9.4.5. Oncology
    9.4.6. Other Applications
    9.6. Middle East & Africa Radiopharmaceutical Market Analysis, Opportunity and Forecast, By End-User, 2016-2032
    9.6.1. Middle East & Africa Radiopharmaceutical Market Analysis by End-User: Introduction
    9.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By End-User, 2016-2032
    9.6.3. Hospitals
    9.6.4. Ambulatory Surgical Centers
    9.6.5. Diagnostic Centers
    9.6.6. Cancer Research Institutes
    9.6.7. Other end-users
    9.CN. Middle East & Africa Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Country , 2016-2032
    9.CN.1. Middle East & Africa Radiopharmaceutical Market Analysis by Country : Introduction
    9.CN.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    9.CN.2.1. Algeria
    9.CN.2.2. Egypt
    9.CN.2.3. Israel
    9.CN.2.4. Kuwait
    9.CN.2.5. Nigeria
    9.CN.2.6. Saudi Arabia
    9.CN.2.7. South Africa
    9.CN.2.8. Turkey
    9.CN.2.9. The UAE
    9.CN.2.10. Rest of MEA
  - 10. Global Radiopharmaceutical Market Analysis, Opportunity and Forecast, By Region , 2016-2032
    10.1. Global Radiopharmaceutical Market Analysis by Region : Introduction
    10.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
    10.2.1. North America
    10.2.2. Western Europe
    10.2.3. Eastern Europe
    10.2.4. APAC
    10.2.5. Latin America
    10.2.6. Middle East & Africa
  - 11. Global Radiopharmaceutical Market Competitive Landscape, Market Share Analysis, and Company Profiles
    11.1. Market Share Analysis
    11.2. Company Profiles
    11.3. Cardinal Health
    11.3.1. Company Overview
    11.3.2. Financial Highlights
    11.3.3. Product Portfolio
    11.3.4. SWOT Analysis
    11.3.5. Key Strategies and Developments
    11.4. GE Healthcare
    11.4.1. Company Overview
    11.4.2. Financial Highlights
    11.4.3. Product Portfolio
    11.4.4. SWOT Analysis
    11.4.5. Key Strategies and Developments
    11.5. Lantheus Medical Imaging
    11.5.1. Company Overview
    11.5.2. Financial Highlights
    11.5.3. Product Portfolio
    11.5.4. SWOT Analysis
    11.5.5. Key Strategies and Developments
    11.6. Bayer AG
    11.6.1. Company Overview
    11.6.2. Financial Highlights
    11.6.3. Product Portfolio
    11.6.4. SWOT Analysis
    11.6.5. Key Strategies and Developments
    11.7. NTP Radioisotopes
    11.7.1. Company Overview
    11.7.2. Financial Highlights
    11.7.3. Product Portfolio
    11.7.4. SWOT Analysis
    11.7.5. Key Strategies and Developments
    11.8. JSC Isotope
    11.8.1. Company Overview
    11.8.2. Financial Highlights
    11.8.3. Product Portfolio
    11.8.4. SWOT Analysis
    11.8.5. Key Strategies and Developments
    11.9. NorthStar Medical Radioisotopes
    11.9.1. Company Overview
    11.9.2. Financial Highlights
    11.9.3. Product Portfolio
    11.9.4. SWOT Analysis
    11.9.5. Key Strategies and Developments
    11.10. Eckert & Ziegler
    11.10.1. Company Overview
    11.10.2. Financial Highlights
    11.10.3. Product Portfolio
    11.10.4. SWOT Analysis
    11.10.5. Key Strategies and Developments
    11.11. Braun Melsungen AG
    11.11.1. Company Overview
    11.11.2. Financial Highlights
    11.11.3. Product Portfolio
    11.11.4. SWOT Analysis
    11.11.5. Key Strategies and Developments
    11.12. Smith & Nephew plc
    11.12.1. Company Overview
    11.12.2. Financial Highlights
    11.12.3. Product Portfolio
    11.12.4. SWOT Analysis
    11.12.5. Key Strategies and Developments
    11.13. Other key players
    11.13.1. Company Overview
    11.13.2. Financial Highlights
    11.13.3. Product Portfolio
    11.13.4. SWOT Analysis
    11.13.5. Key Strategies and Developments
  - 12. Assumptions and Acronyms
  - 13. Research Methodology
  - 14. Contact
  - List of Figures
    Figure 1: Global Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Type in 2022
    Figure 2: Global Radiopharmaceutical Market Attractiveness Analysis by Type, 2016-2032
    Figure 3: Global Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Applicationin 2022
    Figure 4: Global Radiopharmaceutical Market Attractiveness Analysis by Application, 2016-2032
    Figure 5: Global Radiopharmaceutical Market Revenue (US$ Mn) Market Share by End-Userin 2022
    Figure 6: Global Radiopharmaceutical Market Attractiveness Analysis by End-User, 2016-2032
    Figure 7: Global Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Region in 2022
    Figure 8: Global Radiopharmaceutical Market Attractiveness Analysis by Region, 2016-2032
    Figure 9: Global Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Figure 10: Global Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Region (2016-2032)
    Figure 11: Global Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Figure 12: Global Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Figure 13: Global Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Figure 14: Global Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
    Figure 15: Global Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Figure 16: Global Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Figure 17: Global Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Figure 18: Global Radiopharmaceutical Market Share Comparison by Region (2016-2032)
    Figure 19: Global Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Figure 20: Global Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Figure 21: Global Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Figure 22: North America Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Typein 2022
    Figure 23: North America Radiopharmaceutical Market Attractiveness Analysis by Type, 2016-2032
    Figure 24: North America Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Applicationin 2022
    Figure 25: North America Radiopharmaceutical Market Attractiveness Analysis by Application, 2016-2032
    Figure 26: North America Radiopharmaceutical Market Revenue (US$ Mn) Market Share by End-Userin 2022
    Figure 27: North America Radiopharmaceutical Market Attractiveness Analysis by End-User, 2016-2032
    Figure 28: North America Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Country in 2022
    Figure 29: North America Radiopharmaceutical Market Attractiveness Analysis by Country, 2016-2032
    Figure 30: North America Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Figure 31: North America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Figure 32: North America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Figure 33: North America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Figure 34: North America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Figure 35: North America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Figure 36: North America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Figure 37: North America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Figure 38: North America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Figure 39: North America Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Figure 40: North America Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Figure 41: North America Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Figure 42: North America Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Figure 43: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Typein 2022
    Figure 44: Western Europe Radiopharmaceutical Market Attractiveness Analysis by Type, 2016-2032
    Figure 45: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Applicationin 2022
    Figure 46: Western Europe Radiopharmaceutical Market Attractiveness Analysis by Application, 2016-2032
    Figure 47: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Market Share by End-Userin 2022
    Figure 48: Western Europe Radiopharmaceutical Market Attractiveness Analysis by End-User, 2016-2032
    Figure 49: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Country in 2022
    Figure 50: Western Europe Radiopharmaceutical Market Attractiveness Analysis by Country, 2016-2032
    Figure 51: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Figure 52: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Figure 53: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Figure 54: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Figure 55: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Figure 56: Western Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Figure 57: Western Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Figure 58: Western Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Figure 59: Western Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Figure 60: Western Europe Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Figure 61: Western Europe Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Figure 62: Western Europe Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Figure 63: Western Europe Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Figure 64: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Typein 2022
    Figure 65: Eastern Europe Radiopharmaceutical Market Attractiveness Analysis by Type, 2016-2032
    Figure 66: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Applicationin 2022
    Figure 67: Eastern Europe Radiopharmaceutical Market Attractiveness Analysis by Application, 2016-2032
    Figure 68: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Market Share by End-Userin 2022
    Figure 69: Eastern Europe Radiopharmaceutical Market Attractiveness Analysis by End-User, 2016-2032
    Figure 70: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Country in 2022
    Figure 71: Eastern Europe Radiopharmaceutical Market Attractiveness Analysis by Country, 2016-2032
    Figure 72: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Figure 73: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Figure 74: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Figure 75: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Figure 76: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Figure 77: Eastern Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Figure 78: Eastern Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Figure 79: Eastern Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Figure 80: Eastern Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Figure 81: Eastern Europe Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Figure 82: Eastern Europe Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Figure 83: Eastern Europe Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Figure 84: Eastern Europe Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Figure 85: APAC Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Typein 2022
    Figure 86: APAC Radiopharmaceutical Market Attractiveness Analysis by Type, 2016-2032
    Figure 87: APAC Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Applicationin 2022
    Figure 88: APAC Radiopharmaceutical Market Attractiveness Analysis by Application, 2016-2032
    Figure 89: APAC Radiopharmaceutical Market Revenue (US$ Mn) Market Share by End-Userin 2022
    Figure 90: APAC Radiopharmaceutical Market Attractiveness Analysis by End-User, 2016-2032
    Figure 91: APAC Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Country in 2022
    Figure 92: APAC Radiopharmaceutical Market Attractiveness Analysis by Country, 2016-2032
    Figure 93: APAC Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Figure 94: APAC Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Figure 95: APAC Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Figure 96: APAC Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Figure 97: APAC Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Figure 98: APAC Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Figure 99: APAC Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Figure 100: APAC Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Figure 101: APAC Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Figure 102: APAC Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Figure 103: APAC Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Figure 104: APAC Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Figure 105: APAC Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Figure 106: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Typein 2022
    Figure 107: Latin America Radiopharmaceutical Market Attractiveness Analysis by Type, 2016-2032
    Figure 108: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Applicationin 2022
    Figure 109: Latin America Radiopharmaceutical Market Attractiveness Analysis by Application, 2016-2032
    Figure 110: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Market Share by End-Userin 2022
    Figure 111: Latin America Radiopharmaceutical Market Attractiveness Analysis by End-User, 2016-2032
    Figure 112: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Country in 2022
    Figure 113: Latin America Radiopharmaceutical Market Attractiveness Analysis by Country, 2016-2032
    Figure 114: Latin America Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Figure 115: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Figure 116: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Figure 117: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Figure 118: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Figure 119: Latin America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Figure 120: Latin America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Figure 121: Latin America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Figure 122: Latin America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Figure 123: Latin America Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Figure 124: Latin America Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Figure 125: Latin America Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Figure 126: Latin America Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Figure 127: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Typein 2022
    Figure 128: Middle East & Africa Radiopharmaceutical Market Attractiveness Analysis by Type, 2016-2032
    Figure 129: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Applicationin 2022
    Figure 130: Middle East & Africa Radiopharmaceutical Market Attractiveness Analysis by Application, 2016-2032
    Figure 131: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Market Share by End-Userin 2022
    Figure 132: Middle East & Africa Radiopharmaceutical Market Attractiveness Analysis by End-User, 2016-2032
    Figure 133: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Market Share by Country in 2022
    Figure 134: Middle East & Africa Radiopharmaceutical Market Attractiveness Analysis by Country, 2016-2032
    Figure 135: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Figure 136: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Figure 137: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Figure 138: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Figure 139: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Figure 140: Middle East & Africa Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Figure 141: Middle East & Africa Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Figure 142: Middle East & Africa Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Figure 143: Middle East & Africa Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Figure 144: Middle East & Africa Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Figure 145: Middle East & Africa Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Figure 146: Middle East & Africa Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Figure 147: Middle East & Africa Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
  - List of Tables
    Table 1: Global Radiopharmaceutical Market Comparison by Type (2016-2032)
    Table 2: Global Radiopharmaceutical Market Comparison by Application (2016-2032)
    Table 3: Global Radiopharmaceutical Market Comparison by End-User (2016-2032)
    Table 4: Global Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Region (2016-2032)
    Table 5: Global Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Table 6: Global Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Region (2016-2032)
    Table 7: Global Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Table 8: Global Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Table 9: Global Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Table 10: Global Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
    Table 11: Global Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Table 12: Global Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Table 13: Global Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Table 14: Global Radiopharmaceutical Market Share Comparison by Region (2016-2032)
    Table 15: Global Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Table 16: Global Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Table 17: Global Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Table 18: North America Radiopharmaceutical Market Comparison by Application (2016-2032)
    Table 19: North America Radiopharmaceutical Market Comparison by End-User (2016-2032)
    Table 20: North America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 21: North America Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Table 22: North America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 23: North America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Table 24: North America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Table 25: North America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Table 26: North America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Table 27: North America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Table 28: North America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Table 29: North America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Table 30: North America Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Table 31: North America Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Table 32: North America Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Table 33: North America Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Table 34: Western Europe Radiopharmaceutical Market Comparison by Type (2016-2032)
    Table 35: Western Europe Radiopharmaceutical Market Comparison by Application (2016-2032)
    Table 36: Western Europe Radiopharmaceutical Market Comparison by End-User (2016-2032)
    Table 37: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 38: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Table 39: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 40: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Table 41: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Table 42: Western Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Table 43: Western Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Table 44: Western Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Table 45: Western Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Table 46: Western Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Table 47: Western Europe Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Table 48: Western Europe Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Table 49: Western Europe Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Table 50: Western Europe Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Table 51: Eastern Europe Radiopharmaceutical Market Comparison by Type (2016-2032)
    Table 52: Eastern Europe Radiopharmaceutical Market Comparison by Application (2016-2032)
    Table 53: Eastern Europe Radiopharmaceutical Market Comparison by End-User (2016-2032)
    Table 54: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 55: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Table 56: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 57: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Table 58: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Table 59: Eastern Europe Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Table 60: Eastern Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Table 61: Eastern Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Table 62: Eastern Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Table 63: Eastern Europe Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Table 64: Eastern Europe Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Table 65: Eastern Europe Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Table 66: Eastern Europe Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Table 67: Eastern Europe Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Table 68: APAC Radiopharmaceutical Market Comparison by Type (2016-2032)
    Table 69: APAC Radiopharmaceutical Market Comparison by Application (2016-2032)
    Table 70: APAC Radiopharmaceutical Market Comparison by End-User (2016-2032)
    Table 71: APAC Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 72: APAC Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Table 73: APAC Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 74: APAC Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Table 75: APAC Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Table 76: APAC Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Table 77: APAC Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Table 78: APAC Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Table 79: APAC Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Table 80: APAC Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Table 81: APAC Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Table 82: APAC Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Table 83: APAC Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Table 84: APAC Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Table 85: Latin America Radiopharmaceutical Market Comparison by Type (2016-2032)
    Table 86: Latin America Radiopharmaceutical Market Comparison by Application (2016-2032)
    Table 87: Latin America Radiopharmaceutical Market Comparison by End-User (2016-2032)
    Table 88: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 89: Latin America Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Table 90: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 91: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Table 92: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Table 93: Latin America Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Table 94: Latin America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Table 95: Latin America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Table 96: Latin America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Table 97: Latin America Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Table 98: Latin America Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Table 99: Latin America Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Table 100: Latin America Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Table 101: Latin America Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
    Table 102: Middle East & Africa Radiopharmaceutical Market Comparison by Type (2016-2032)
    Table 103: Middle East & Africa Radiopharmaceutical Market Comparison by Application (2016-2032)
    Table 104: Middle East & Africa Radiopharmaceutical Market Comparison by End-User (2016-2032)
    Table 105: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 106: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) (2016-2032)
    Table 107: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Country (2016-2032)
    Table 108: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Type (2016-2032)
    Table 109: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Comparison by Application (2016-2032)
    Table 110: Middle East & Africa Radiopharmaceutical Market Revenue (US$ Mn) Comparison by End-User (2016-2032)
    Table 111: Middle East & Africa Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
    Table 112: Middle East & Africa Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
    Table 113: Middle East & Africa Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
    Table 114: Middle East & Africa Radiopharmaceutical Market Y-o-Y Growth Rate Comparison by End-User (2016-2032)
    Table 115: Middle East & Africa Radiopharmaceutical Market Share Comparison by Country (2016-2032)
    Table 116: Middle East & Africa Radiopharmaceutical Market Share Comparison by Type (2016-2032)
    Table 117: Middle East & Africa Radiopharmaceutical Market Share Comparison by Application (2016-2032)
    Table 118: Middle East & Africa Radiopharmaceutical Market Share Comparison by End-User (2016-2032)
- Cardinal Health
- GE Healthcare
- Lantheus Medical Imaging
- Bayer AG Company Profile
- NTP Radioisotopes
- JSC Isotope
- NorthStar Medical Radioisotopes
- Eckert & Ziegler
- B. Braun Melsungen AG Company Profile
- Smith & Nephew plc
- Other key players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)